Clinical and histological features of leprosy and human immunodeficiency virus co-infection in Brazil

Clinical and Experimental Dermatology

Volumn 38, Issue 5, 2013, Pages 470-477

  Deps, P ^a   Lucas, S ^b   Porro, A M ^c   Maeda, S M ^c   Tomimori, J ^c   Guidella, C ^d   Reuter, T ^a   Oliveira, N S ^e   Madureira, B P R ^a   Souza, V A ^a   Loureiro, R M ^a   Alves, B L ^a   Bellone, A ^e   Lockwood, D N J ^f  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d Center for Sanitary Dermatology   (Brazil)

^e Sector of Microbiology   (Brazil)

^f HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; ARTICLE; BRAZIL; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DERMATITIS; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LEPROSY; MALE; MIXED INFECTION; PRIORITY JOURNAL; SKIN BIOPSY; SKIN EDEMA; SKIN GRANULOMA; SKIN NECROSIS; TUBERCULOID LEPROSY;

ADULT; AGED; BRAZIL; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; COINFECTION; FEMALE; HIV INFECTIONS; HUMANS; LEPROSY; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84879195291     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/ced.12028     Document Type: Article

References (19)

1. Lawn SD, Wood C, Lockwood DN,. Borderline tuberculoid leprosy: an immune reconstitution phenomenon in a human immunodeficiency virus-infected person. Clin Infect Dis 2003; 36: e5-6.
2. Deps PD, Lockwood DJN,. Leprosy presenting as immune reconstitution inflammatory syndrome: proposed definitions and classification. Lepr Rev 2010; 81: 59-68.
3. World Health Organization. Leprosy elimination. New cases detection. Available at: http://www.who.int/lep/situation/new-cases/en/index.html (accessed 12 February 2012).
4. UNAIDS. 2011 Political Declaration: Targets and elimination commitments. Available at: http://www.unaids.org/en/targetsandcommitments/ (accessed 12 February 2012).
5. United Nations Programme on HIV/AIDS and World Health Organization. Report on the global HIV/AIDS epidemic. Fourth Global Report, 2004. Available at: http://data.unaids.org/Global-Reports/Bangkok-2004/unaidsbangkokpress/ gar2004html/gar2004-00-en.htm (accessed 20 January 2011).
6. Lucas SB,. Human immunodeficiency virus and leprosy. Lepr Rev 1993; 64: 97-103.
7. Naafs B,. Leprosy and HIV: an analysis. Hansen Int 2000; 25: 63-6.
8. Battegay M, Nuesch R, Hirschel B, et al,. Immunological recovery and antiretroviral therapy in HIV-1 infection. Lancet Infect Dis 2006; 6: 280-7.
9. Lockwood DN, Lucas SB, Desikan KV, et al,. The histological diagnosis of leprosy type 1 reactions: identification of key variables and an analysis of the process of histological diagnosis. J Clin Pathol 2008; 61: 595-600.
10. Nery JAC, Sa RP, Guatierrez MC, et al,. Reactional states in co-infected leprosy x HIV positive patients. Abstracts of the 16th International Leprosy Congress, Salvador-BA, Brazil, 2002; 74.
11. Harboe M,. Immunology. Overview of host-parasite relations. In: Leprosy, 2nd edn (, Hastins RC, ed.). London: Churchill Livingstone, 1994: 87-112.
12. Modlin RL, Hofman FM, Meyer PR, et al,. In situ demonstration of T lymphocyte subsets in granulomarous inflammation: leprosy, rhinoscleroma and sarcoidosis. Clin Exp Immunol 1983; 51: 430-8.
13. Mishra BB, Pouter LW, Janossy G, et al,. The distribution of lymphoid and macrophage like cell subsets of sarcoid and Kveim granulomata: possible mechanism of negative PPD reaction in sarcoidosis. Clin Exp Immunol 1983; 54: 705-15.
14. Nery JAC, Sampaio EP, Galhardo MCG, et al,. M. leprae-HIV co-infection: pattern of immune response in vivo and in vitro. Indian J Lepr 2000; 72: 155-67.
15. Sarno EN, Illarramendi X, Nery JA, et al,. HIV-M. leprae interaction: can HAART modify the course of leprosy? Public Health Rep 2008; 123: 206-12.
16. Council for International Organizations of Medical Sciences/World Health Organization. International ethical guidelines for biomedical research involving human subjects. Available at: http://www.cioms.ch/frame-guidelines-nov- 2002htm (accessed on 26 March 2010).
17. World Health Organization. Diagnosis of leprosy, 2007. Available at: http://www.who.int/lep/diagnosis/en/index.html (accessed 2 April 2010)
18. Ridley DS, Jopling WH,. Classification of leprosy according to immunity: a five-group system. Int J Lepr Other Mycobact Dis 1966; 34: 255-73.
19. van Brakel WH, Nicholls PG, Das L, et al,. The INFIR Cohort Study. Investigating prediction, detection and pathogenesis of neuropathy and reactions in Leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India. Lepr Rev 2005; 76: 14-34.